Viewing Study NCT03906058


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2025-12-25 @ 9:59 PM
Study NCT ID: NCT03906058
Status: COMPLETED
Last Update Posted: 2023-10-25
First Post: 2019-04-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module